Clover Health Investments, Corp.
Clover Health Investments, Corp. (CLOV) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
clov · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Hold
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$4.20
Consensus
$4.20
+8.0% upside
Low
$4.20
Median: $4.2 · Last Close: $3.89
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.05 | ↑ 4.12% |
1-day model range: $4.01–$4.09. Peak: $4.09 (+4.12%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | +41.2% |
| 2028 | $7 | +76.1% |
| 2029 | $8 | +102.2% |
| 2030 | $9 | +120.2% |
| 2031 | — | +132.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLOV · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-20 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-05 | Leerink Partners | Maintains | Market Perform→Market Perform |
| 2026-01-20 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-06 | UBS | Maintains | Neutral→Neutral |
| 2025-03-03 | Canaccord Genuity | Maintains | Buy→Buy |
| 2023-08-11 | Citigroup | Maintains | Neutral→Neutral |
| 2023-03-06 | Credit Suisse | Maintains | Underperform→Underperform |
Wall Street analysts have recently issued updated ratings on Clover Health Investments, Corp. (CLOV) stock. Of the recent 24 rating actions, 1 were upgrades and 4 were downgrades. 9 analysts currently cover CLOV.
Analyst Recommendation Trends
CLOV analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.9B
↓ 20.6% YoY
Revenue Next Year
$3.3B
↑ 14.2% YoY
EPS This Year
$0.04
EPS Next Year
$0.05
↑ 30.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLOV EPS of $0.04 for the current fiscal year, based on estimates from 1 analysts. The CLOV revenue forecast is $2.9B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CLOV stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLOV price target is $4.20 (+8.0% upside), with an analyst consensus of Hold.
The CLOV short-term stock prediction for tomorrow is $4.05 (+4.12%). The CLOV stock price prediction for 2027 estimates an average of $5. The CLOV stock prediction for 2030 projects a range of $8–$9.
Clover Health Investments, Corp. trades on NASDAQ under the ticker CLOV. The CLOV stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 11% of covering analysts.
Frequently asked questions
CLOV forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month CLOV price target is $4.20, with a high forecast of $4.20 and a low of $4.20. The median price target is shown in the chart above when available. This implies +8.0% potential upside from the current price of $3.89.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.